Introduction
============

Physiological and pathological changes observed in older people appear to affect the mechanism of action of drugs and the function of the various structures involved. In older people we find upgrading and alterations in the number of receptors, changes in signal transduction (function of second messengers), and differences in intracellular response. Renal and hepatic functions can be altered as well, with consequences found for the pharmacokinetics of administered drugs. This may explain why in older people there is sometimes a greater sensitivity to the effects of certain drugs and sometimes a diminished response to therapy. Regimens that are safe for other age groups may be inappropriate for geriatric patients.[@b1-dhps-4-075] Moreover, older patients often use multiple drugs: it has been calculated that about 80% of patients over 65 years of age take medications and that about 40% are taking five or more drugs regularly.[@b2-dhps-4-075],[@b3-dhps-4-075]

As the benefits of medications are always accompanied by harmful effects, it is not surprising that older people are at increased risk of developing adverse drug reactions (ADRs). Several studies have been conducted on ADRs as a cause of admission to hospital in the older population,[@b4-dhps-4-075]--[@b7-dhps-4-075] and in a meta-analysis of observational studies, the percentage of ADR-related hospital admissions was reported to be four times higher in older than in younger patients (16.6% versus 4.1%).[@b8-dhps-4-075] In a recent systematic review of 25 studies of hospital admissions associated with ADRs, the admission rate for older patients was 10.7%, much higher than for adults in general (6.3%) or for children (4.1%).[@b9-dhps-4-075] Fewer studies have focused on ADRs occurring in older patients during their stay in hospital, reporting a prevalence of ADRs ranging from 13.6% to 46.2%.[@b10-dhps-4-075]--[@b13-dhps-4-075]

We conducted an observational prospective study that aimed to calculate the frequency of adverse drug reactions in older patients, both ADRs causing hospital admission and those occurring during patients' stay in hospital, and to describe the types of reactions and associated drugs. The study also had the educational objective of encouraging health care providers to report ADRs to the national pharmacovigilance system and of facilitating collaboration between medical and nursing staff.

Methods
=======

Patients and data collection
----------------------------

The study was carried out in three geriatric wards (97 beds) of the Verona University Hospital in northern Italy. All patients aged 65 years and over who were admitted to these wards between February and July 2009 were included. Patients coming from, or transferred within 24 hours to, other hospital wards were excluded from the study.

Each patient's age and sex, the date, and their diagnosis at admission were registered by nurses on a special form. During their time in hospital, patients were monitored for the occurrence of drug-related problems. In the case of admissions due to an ADR, or of an ADR occurring during hospital stay, the type of reactions and the suspected drugs were registered by nurses and physicians involved in the study. At each patient discharge the completed form was discussed and validated by physicians.

Data analysis
-------------

An ADR was defined as an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration, and which warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product.[@b14-dhps-4-075] Reactions were classified following the World Health Organization Adverse Reaction Terminology (WHO-ART). According to the WHO classification of the severity of ADRs, any reaction leading to hospitalization was considered serious, while the severity classification of reactions occurring during patients' stay in hospital was carried out by physicians case by case, on the basis of the patient's symptoms and the cited WHO criteria.[@b15-dhps-4-075]

Nurses and physicians involved in the study were invited to report ADRs to the national pharmacovigilance system, in accordance with Italian law.

Means, percentages, and their 95% confidence intervals (95% CI) were used to compare the characteristics of patients and length of hospital stay in the three groups of patients (without ADR, with ADR as cause of hospitalization, and with ADR during hospitalization).

Results
=======

During the 6 months of the study, 1215 patients were hospitalized in the three geriatrics departments. Of these patients, 1023 (84%) matched the inclusion criteria and were included in the study. The patients' mean age was 81.9 (95% CI: 81.5--82.3) years. The women's mean age (83.0, 95% CI: 82.4--83.6) proved significantly higher than the men's (80.7, 95% CI: 80.1--81.3), in line with the composition of the Italian population. The age of patients with ADRs (82.4, 95% CI: 81.7--83.1) was not statistically different from that of patients without ADRs (81.6, 95% CI: 81.0--82.2).

[Table 1](#t1-dhps-4-075){ref-type="table"} shows the frequency of patients without and with ADRs, and the duration of their stay in hospital. Altogether a total of 370 patients developed an ADR; for 114 of them the reactions were the cause of hospital admission, while for 256 patients ADRs occurred during hospital stay. The frequency of admissions caused by an ADR was higher in women than in men, although the difference was not significant. The frequency of women who had ADRs during hospital stay was also higher than that of men, but again the difference was not significant. As shown in [Table 1](#t1-dhps-4-075){ref-type="table"}, the duration of hospital stay was longer in patients who developed an ADR during their time in hospital, whether male or female.

The rate of hospital admissions was constant during the first four months of the study, with a decrease in the last 2 months that corresponded with the general decrease in the number of hospital admissions in summer. The monthly number of patients hospitalized because of ADR and of those who had an ADR during their stay in hospital was also relatively constant.

[Table 2](#t2-dhps-4-075){ref-type="table"} shows the main ADRs and related drugs which caused hospital admission. Electrolyte disorders were the most frequently observed ADRs; among this group of reactions hyponatremia was the most common, followed by hypokalemia and hyperkalemia. Potassium-sparing diuretics, anti-ulcers, and angiotensin-converting-enzyme (ACE) inhibitors were the drugs most often associated with electrolyte disorders. On the whole, 84 drugs were responsible for hospital admission, of which the most frequently involved were diuretics, antithrombotic agents (anticoagulants and antiplatelets), and ACE inhibitors.

Among the 60 different ADR diagnoses issued during patients' time in hospital, electrolyte disorders were again the most frequently reported, although in a different order to that of adverse drug reactions leading to hospitalization ([Table 3](#t3-dhps-4-075){ref-type="table"}). Other systemic ADRs frequently observed were anemia, increase of International Normalized Ratio (INR), diarrhea, and rash. More than half of the ADRs (53.5%) that occurred during hospital stay were classified by physicians as serious. Altogether, 73 different drugs were considered responsible for ADRs. The most frequently involved classes of drugs were diuretics, antithrombotic agents, and antibacterials. Furosemide (83 cases), enoxaparin (31 cases), warfarin (17 cases), and ampicillin plus sulbactam (16 cases) were the drugs most frequently associated with ADRs in hospitalized patients.

During the 6 months of the study, 32 reports of ADRs were sent to the Italian pharmacovigilance system. Of these, 20 (87.5%) reported a serious ADR. A total of 72% of reports were sent by physicians, the others by nurses. These reports represented only 14% of the ADRs causing hospital admission and 6.2% of those occurring during hospital stay in patients included in the study.

Discussion
==========

Our data show that 11.1% of admissions to three geriatric departments of the University Hospital of Verona were related to ADRs. This percentage is the same as that found in the systematic review by Kongkaev et al[@b9-dhps-4-075] and is slightly lower than that found in the meta-analysis by Beijer and de Blaey.[@b8-dhps-4-075] On the other hand, the number of drug-related admissions reported in the present study is significantly higher than that found by other researchers in our country. ADRs were considered to be the cause of hospitalization in 3.8% of all admissions in a multicenter pharmacoepidemiology survey conducted in Italy between 1988 and 1997, involving more than 28,000 older patients.[@b5-dhps-4-075] Moreover, in a more recent Italian prospective analysis of 1756 medical records of older patients, the proportion of drug-related admission was 5.8%.[@b6-dhps-4-075] It should be emphasized that in our study the mean age (±SD) of patients was 81.9 ± 7.1 years, while in earlier Italian studies patients were younger. For instance, in the study by Franceschi et al,[@b6-dhps-4-075] the average age of hospitalized patients was 76.5 ± 7.4 years, significantly different from our data (*t*-test, *P* \< 0.01). It is known that with increasing age, patients become more frail and take more drugs, both of which lead to a higher risk of ADR.[@b2-dhps-4-075],[@b3-dhps-4-075] It is also worth recalling that some recent studies showed that ADR-related hospital admissions of older people have increased over the last decades, so close attention to this problem is warranted.[@b16-dhps-4-075],[@b17-dhps-4-075]

In the present study, the percentage of ADRs in patients during their hospital stay was 25%, in line with previous studies of older patients.[@b10-dhps-4-075]--[@b13-dhps-4-075] Recently a large prospective study among UK hospital in-patients with an average age of 63 years suggested that at least 1 in 7 inpatient episodes are complicated by an adverse drug reaction.[@b18-dhps-4-075] The widely differing estimates of ADR percentage in various studies may be explained by differences in data collection methods, in definitions of ADR, characteristics of patients, typology of wards involved, and duration of hospital stay. In our study the occurrence of an ADR during hospital stay increased the median length of that stay by 50%, in line with the literature.[@b12-dhps-4-075],[@b13-dhps-4-075],[@b18-dhps-4-075],[@b19-dhps-4-075]

In this study, the mean age of patients with ADRs did not differ from the age of patients without ADRs, in contrast with reports by other researchers of a higher median age in ADR patients than in non-ADR groups.[@b18-dhps-4-075],[@b20-dhps-4-075] This may be due to the fact that our data come from a geriatric setting and the mean age of all patients included was very high. The slightly higher percentage of ADRs in women compared to men found in our study concurs with previous findings that female sex is a risk factor for the development of ADRs.[@b21-dhps-4-075] Some studies have also documented that women are at higher risk than men of hospitalization because of an ADR,[@b5-dhps-4-075],[@b20-dhps-4-075] although other investigations were not able to confirm this finding.[@b4-dhps-4-075],[@b7-dhps-4-075] Known reasons for sex-related vulnerability to ADRs include differences in pharmacokinetics leading to possible under or over-exposure to drugs in women, as well as differences in the pattern of drug use. Female sex has been associated with polypharmacy in elderly people as well.[@b22-dhps-4-075],[@b23-dhps-4-075]

Alterations in sodium and potassium blood levels, blood disorders including anemia and international normalized ratio (INR) increase, gastrointestinal disorders, and syncope were the reactions most frequently involved in drug-related hospital admissions. This is quite consistent with data found in the prospective study by Olivier et al,[@b7-dhps-4-075] where hematological complaints (26%), metabolic (20%) and neurological disorders (18%), and cardiovascular problems (17%) represented the most common ADRs leading to hospitalization. On the other hand, in the study by Franceschi et al[@b6-dhps-4-075] gastrointestinal disorders (mainly bleeding and peptic ulcer related to nonsteroidal anti-inflammatory drug use) accounted for nearly one half of ADR-related hospitalizations (47% versus 12% in our study), followed by disorders of the hematopoietic (20%) and cardiovascular (13%) systems. Again, the difference in age between the two study populations may in part explain these differences. It is also to be noted that, in Italy in recent years, upper-gastrointestinal bleeding has been more and more frequently treated by endoscopy, and patients are not usually admitted to hospital for this procedure.[@b24-dhps-4-075]

In older outpatients, electrolyte abnormalities are quite common and can relate to many factors such as frequency and dose of drug therapy, concurrent assumption of incompatible salts, failure to replace a needed electrolyte, hydration state, and inadequate monitoring. Prescription of diuretics in UK primary care has been associated with a high frequency of hyponatremia and hypokalemia.[@b25-dhps-4-075] The researchers showed that hyponatremia was significantly associated with increased age: the odds ratio for developing hyponatremia in patients over the age of 70 years was 3.87 compared with those of ≤70 years. It is now known that hyponatremia can occur several days or months after the initiation of proton pump inhibitors, although these drugs were initially overlooked as a cause of hyponatremia. A case of hyponatremic delirium leading to rhabdomyolysis has also been reported.[@b26-dhps-4-075] It is well known that potassium level alterations are responsible for conduction disturbances, dangerous arrhythmias, cardiogenic syncope, and sudden cardiac death. Hyperkalemia may develop as a complication of therapy with ACE inhibitors or angiotensin-2 receptor blockers in elderly patients with common associated risk factors that interfere with renal excretion of potassium, such as advanced age, female sex, reduced renal functional reserve, and decreased renal perfusion.[@b27-dhps-4-075],[@b28-dhps-4-075] As a consequence, especially frail older patients at high risk of electrolyte imbalance should be monitored closely by general practitioners to avoid acute life-threatening cardiac events. Hospital admission caused by INR increase in warfarin-treated patients and renal failure related to drugs could probably be avoided, especially with close monitoring of patients during therapy.

Electrolyte disturbances associated with cardiovascular and antiulcer drugs were also the ADRs most frequently observed during hospital stay. This finding is in agreement with the study by Passarelli et al who identified hypokalemia associated with diuretics as the most prevalent ADR in an older hospitalized population.[@b13-dhps-4-075] In the analysis by Davies et al, electrolyte disturbances associated with loop diuretics were the most frequently occurring ADR,[@b18-dhps-4-075] which is in line with our data. The relatively high number of ADRs caused by application-site disorders in the present study probably relates to the involvement of nurses in the project, and shows how they can cooperate with physicians in detecting and reporting ADRs. Good communication among health care providers is pivotal to the development of an effective therapeutic partnership with the patient, and can improve patients' drug adherence.

The use of inappropriate drugs is widely recognized as one of the major factors influencing the risk of ADRs in older patients, along with the lack of patient monitoring during hospitalization.[@b1-dhps-4-075],[@b29-dhps-4-075] The review of 17 articles by Howard et al shows that about 50% of ADRs that caused hospital admission were preventable.[@b30-dhps-4-075] Even with regard to ADRs during hospital stay, the literature shows that a high percentage could have been avoided.[@b18-dhps-4-075] Our study did not focus on inappropriate medications, but most drug-related electrolyte disturbances detected as causing or occurring during hospitalization could be avoided by close monitoring of patients with simple, routine blood tests.

The low number of ADR reports sent to the national pharmacovigilance system by physicians and nurses, despite their involvement in the study, is indicative of the poor adherence of Italian health care providers to pharmacovigilance.

In conclusion, our study confirms that ADRs are an important cause of hospitalization in older patients. In addition, the percentage of ADRs occurring during hospital stay is high and causes prolonged hospitalization, with a significant impact on health care costs.

The authors regret to announce the passing of Dr Davide Costantini on 7 April, 2012.
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###### 

Patients and length of hospitalization, subdivided according to ADR appearance and sex

                                                                 All (n = 1023)      Women (n = 520)     Men (n = 503)
  -------------------------------------------------------------- ------------------- ------------------- -------------------
  Patients without ADR (% \[95% CI\])                            65.4 (60.9--66.7)   63.1 (58.9--67.2)   67.8 (63.7--71.9)
  Days of hospital stay, mean (95% CI)                           12.6 (11.9--13.3)   12.6 (11.5--13.7)   12.6 (11.6--13.6)
  Patients with ADR as cause of hospitalization (% \[95% CI\])   11.1 (9.2--13.0)    12.1 (9.3--14.9)    10.1 (7.5--12.8)
  Days of hospital stay, mean (95% CI)                           13.6 (11.9--15.3)   15.2 (12.6--17.8)   11.5 (9.6--13.4)
  Patients with ADR during hospitalization (% \[95% CI\])        25.0 (22.4--27.7)   27.1 (23.3--30.9)   22.9 (19.2--26.5)
  Days of hospital stay, mean (95% CI)                           18.7 (17.2--20.1)   18.7 (16.8--20.6)   18.7 (16.5--20.9)

**Abbreviations:** ADR, adverse drug reaction; CI, confidence interval; n, number.

###### 

ADRs causing hospital admission, grouped to the System Organ Classification of WHO-ART, and related drugs

  ADRs                                                 Drug classes[\*](#tfn3-dhps-4-075){ref-type="table-fn"}
  ---------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------
  **Metabolic and nutritional disorders (41)**         
  Hyponatremia (21)                                    Potassium-sparing diuretics (13); antiulcer drugs (8); ACE inhibitors (3); antidepressants (3); diuretics (3); angiotensin-2 receptor antagonists (2)
  Hypokalemia (9)                                      Diuretics (5); ACE inhibitors (2)
  Hyperkalemia (8)                                     ACE inhibitors (6); potassium-sparing diuretics (4)
  Hypoglycemia (4)                                     Hypoglycemic agents (4)
  Dehydration (4)                                      Diuretics (3)
  **Red blood cell disorders (16)**                    
  Anemia (14)                                          Antithrombotic agents (6); analgesics and antipyretics (5); antitumorals (4); corticosteroids (2)
  **Body as a whole/general disorders (16)**           
  Syncope (9)                                          ACE inhibitors (4); diuretics (2); beta-blockers (2); calcium channel blockers (2)
  **Gastrointestinal system disorders (15)**           
  Diarrhea (5)                                         Antibacterials (5)
  Vomiting (3)                                         Antibacterials (2)
  **Platelet, bleeding and clotting disorders (12)**   
  INR increase (10)                                    Antithrombotic agents (10)
  **Urinary system disorders (11)**                    
  Renal failure (6)                                    Antibacterials (5); ACE inhibitors (3); potassium-sparing diuretics (2)
  **Psychiatric disorders (10)**                       
  Confusion (5)                                        Antidepressants (2); antipsychotics (2)

**Notes:** Groups of ADRs that occurred in at least 10 patients are shown.

Drug classes suspected in at least two patients are listed. Figures in parentheses indicate the number of patients.

**Abbreviations:** ACE, angiotensin converting enzyme; ADRs, adverse drug reactions; INR, international normalized ratio; WHO-ART, World Health Organization Adverse Reaction Terminology.

###### 

ADRs during hospital stay, grouped according to the System Organ Classification of WHO-ART, and related drugs

  ADRs                                                 Drug classes[\*](#tfn6-dhps-4-075){ref-type="table-fn"}
  ---------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  **Metabolic and nutritional disorders (110)**        
  Hypokalemia (75)                                     Diuretics (73); antithrombotic agents (8); Potassium-sparing diuretics (3); cardiac glycosides (3)
  Hyponatremia (17)                                    Potassium-sparing diuretics (12); diuretics (6); antiulcer agents (4)
  Hyperglycemia (13)                                   Corticosteroids (13)
  Hyperkalemia (12)                                    Potassium-sparing diuretics (8); corticosteroids (2); antiulcer agents (2); antithrombotic agents (2); angiotensin-2 receptor antagonists (2)
  **Gastrointestinal system disorders (34)**           
  Diarrhea (15)                                        Antibacterials (14); antithrombotic agents (2)
  Constipation (10)                                    Analgesics and antipyretics (6); opioids (4)
  **Platelet, bleeding and clotting disorders (31)**   
  INR increase (15)                                    Antithrombotic agents (15); diuretics (3)
  Thrombocytopenia (13)                                Antithrombotic agents (13); diuretics (2)
  **Skin and appendages disorders (31)**               
  Rash erythematosus (15)                              Antibacterials (14); antithrombotic agents (2); diuretics (2)
  Urticaria (5)                                        Antibacterials (2)
  Hyperhidrosis (2)                                    Opioids (2)
  **Application site disorders (20)**                  
  Hematoma at the injection site (18)                  Antithrombotic agents (17); analgesic/antipyretics (2); NSAIDs (2)
  **Red blood cell disorders (19)**                    
  Anemia (19)                                          Antithrombotic agents (17); analgesics and antipyretics (8); diuretics (3)

**Notes:** Groups of ADRs that occurred in at least 10 patients are shown.

Drug classes suspected in at least 2 patients are listed. Figures in parentheses indicate the number of patients.

**Abbreviations:** ADRs, adverse drug reactions; INR, international normalized ratio; NSAIDs, nonsteroidal anti-inflammatory drugs; WHO-ART, World Health Organization Adverse Reaction Terminology.
